In gliomas harboring IDH1-R132H mutations, cells exhibit increased mitochondrial mass, enhanced oxygen consumption, and preferential utilization of substrates like glutamate and pyruvate for ATP production. This evidence concerns the gene IDH1 and central nervous system cancer.